Trial Outcomes & Findings for Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome (NCT NCT03624569)

NCT ID: NCT03624569

Last Updated: 2025-06-15

Results Overview

Fasting serum endotoxin concentration

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

32 participants

Primary outcome timeframe

Day 14

Results posted on

2025-06-15

Participant Flow

Participant milestones

Participant milestones
Measure
Bagel Diet First and Potato Diet
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment). After a washout period of 2 weeks, they then received an identical diet for 2-weeks that contained potatoes instead of bagels (comparator arm).
Potato Diet First and Bagel Diet
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato. After a washout period of 2 weeks, they then received an identical diet for 2-weeks that contained bagels instead of a potatoes (comparator arm).
First Intervention (2 Weeks)
STARTED
20
12
First Intervention (2 Weeks)
COMPLETED
19
10
First Intervention (2 Weeks)
NOT COMPLETED
1
2
Washout (2 Weeks)
STARTED
19
10
Washout (2 Weeks)
COMPLETED
19
10
Washout (2 Weeks)
NOT COMPLETED
0
0
Second Intervention (2 Weeks)
STARTED
19
10
Second Intervention (2 Weeks)
COMPLETED
18
9
Second Intervention (2 Weeks)
NOT COMPLETED
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Bagel Diet First and Potato Diet
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment). After a washout period of 2 weeks, they then received an identical diet for 2-weeks that contained potatoes instead of bagels (comparator arm).
Potato Diet First and Bagel Diet
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato. After a washout period of 2 weeks, they then received an identical diet for 2-weeks that contained bagels instead of a potatoes (comparator arm).
First Intervention (2 Weeks)
Withdrawal by Subject
1
2
Second Intervention (2 Weeks)
Protocol Violation
1
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Baseline Measures - All Participants
n=27 Participants
Baseline Measures of All Participants Prior To Randomization
Age, Continuous
32.5 years
STANDARD_DEVIATION 6.8 • n=27 Participants
Sex: Female, Male
Female
14 Participants
n=27 Participants
Sex: Female, Male
Male
13 Participants
n=27 Participants
Region of Enrollment
United States
27 participants
n=27 Participants
Body mass index (kg/m^2)
35 kg/m^2
STANDARD_DEVIATION 5.1 • n=27 Participants
Waist Circumference (cm)
109.8 cm
STANDARD_DEVIATION 12.2 • n=27 Participants
Systolic Blood Pressure (mmHg)
120.5 mmHg
STANDARD_DEVIATION 8.4 • n=27 Participants
Diastolic Blood Pressure (mmHg)
82.9 mmHg
STANDARD_DEVIATION 5.6 • n=27 Participants
Plasma Glucose (mg/dl)
103.7 mg/dL
STANDARD_DEVIATION 8.1 • n=27 Participants
Plasma High-density Lipoprotein-Cholesterol (mg/dl)
36.7 mg/dL
STANDARD_DEVIATION 7.4 • n=27 Participants
Plasma Triglyceride (mg/dl)
127.6 mg/dL
STANDARD_DEVIATION 80.4 • n=27 Participants
Plasma Ascorbic Acid (umol/L)
40.4 umol/L
STANDARD_DEVIATION 21.2 • n=27 Participants

PRIMARY outcome

Timeframe: Day 14

Fasting serum endotoxin concentration

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Endotoxin
21.2 EU/mL
Standard Deviation 3.0
23.3 EU/mL
Standard Deviation 3.0

PRIMARY outcome

Timeframe: Day 14 Postprandial (0, 30, 60, 90, 120 minutes)

Area under curve (change from baseline) for brachial artery flow-mediated dilation (FMD). The unit for FMD is %, which is calculated as: \[vessel diameter in millimeters (post-occlusion) - vessel diameter in millimeters (pre-occlusion)\] / vessel diameter in millimeters (pre-occlusion) x 100. FMD(%) is then used to caluclate area under the curve based on independent measures of FMD at 0-120 minutes)

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Vascular Endothelial Function
-259 % x min
Standard Error 75
-198 % x min
Standard Error 71

SECONDARY outcome

Timeframe: Fasting glucose on Day 0

Fasting plasma glucose

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting Glucose Day 0
104 mg/dL
Standard Deviation 13.5
109.5 mg/dL
Standard Deviation 14.6

SECONDARY outcome

Timeframe: Fasting glucose on Day 14

Fasting plasma glucose Day 14

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting Glucose Day 14
101.9 mg/dL
Standard Deviation 12.3
102.3 mg/dL
Standard Deviation 13.5

SECONDARY outcome

Timeframe: Fasting insulin on Day 0

Fasting plasma insulin

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting Insulin Day 0
21.1 uIU/mL
Standard Error 5.5
17.0 uIU/mL
Standard Error 2.0

SECONDARY outcome

Timeframe: Fasting insulin on Day 14

Fasting plasma insulin Day 14

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting Insulin Day 14
14.2 uIU/mL
Standard Error 2.0
14.9 uIU/mL
Standard Error 2.4

SECONDARY outcome

Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)

Plasma insulin concentration area under curve change from baseline

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Postprandial Insulin
5940 uIU/mL x min
Standard Error 670
7086 uIU/mL x min
Standard Error 1372

SECONDARY outcome

Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)

Postprandial plasma glucose concentration area under curve change from baseline

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Postprandial Glucose
2649 mg/dL x min
Standard Error 499
2808 mg/dL x min
Standard Error 565

SECONDARY outcome

Timeframe: Day 0

Fasting serum endotoxin concentration

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting Endotoxin
26.6 EU/mL
Standard Error 2.0
22.3 EU/mL
Standard Error 2.1

SECONDARY outcome

Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)

Postprandial serum endotoxin concentration area under curve change from baseline

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Postprandial Endotoxin
450 EU/ml x min
Standard Error 249
-120 EU/ml x min
Standard Error 176

SECONDARY outcome

Timeframe: Day 14, 0-5 hours post-consumption of sugar probes

Urinary concentration of the non-digestible sugars lactulose/mannitol (mg/mg)

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Lactulose/Mannitol Ratio
.154 Ratio (mg/mg)
Standard Error .013
.151 Ratio (mg/mg)
Standard Error 0.1

SECONDARY outcome

Timeframe: Day 14, 6-24 hours post-consumption of sugar probes

Urinary concentration of the non-digestible sugars sucralose/erythritol

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Sucralose/Erythritol Ratio
.0148 Ratio (mg/mg)
Standard Error 0.002
0.01667 Ratio (mg/mg)
Standard Error 0.001925

SECONDARY outcome

Timeframe: Day 14

Fecal concentration of butyrate

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fecal Butyrate
21.3 umol/g
Standard Error 2.7
17.9 umol/g
Standard Error 2.6

SECONDARY outcome

Timeframe: Day 14

Fecal concentration of acetate

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fecal Acetate
52.3 umol/g
Standard Error 4.7
46.6 umol/g
Standard Error 3.9

SECONDARY outcome

Timeframe: Day 14

Fecal concentration of propionate

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fecal Propionate
23.1 umol/g
Standard Error 2.2
19.3 umol/g
Standard Error 2.1

SECONDARY outcome

Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)

Plasma CCK area under curve change from baseline

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Postprandial Cholecystokinin
-196 pmol/L x min
Standard Error 266
-67 pmol/L x min
Standard Error 344

SECONDARY outcome

Timeframe: Day 14

Fasting plasma concentration of CCK

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting Cholecystokinin
14.3 pmol/L
Standard Error 3.1
14.2 pmol/L
Standard Error 3.4

SECONDARY outcome

Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)

Plasma total nitrite/nitrate area under curve change from baseline

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Postprandial NOx
-240 umol/L x min
Standard Error 88
-433 umol/L x min
Standard Error 48

SECONDARY outcome

Timeframe: Day 14

Fasting plasma concentration of nitrite/nitrate

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting NOx
29.8 umol/L x min
Standard Error 3.7
30.1 umol/L x min
Standard Error 2.3

SECONDARY outcome

Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)

Plasma MDA concentration, biomarker of oxidative stress area under curve change from baseline

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Postprandial Malondialdehyde (MDA)
57.2 umol/L x min
Standard Error 6.8
45.4 umol/L x min
Standard Error 7.2

SECONDARY outcome

Timeframe: Day 14

Fasting plasma MDA concentration, biomarker of oxidative stress

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting Malondialdehyde (MDA)
1.78 umol/L
Standard Error .1
1.93 umol/L
Standard Error .1

SECONDARY outcome

Timeframe: Day 14

Fasting flow-mediated dilation of the brachial artery. Measure is calculated as: \[post-occlusion vessel diameter (mm) - pre-occlusion vessel diameter (mm) / pre-occlusion vessel diameter (mm)\] x 100

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Fasting Vascular Endothelial Function
7.2 % change in blood vessel dilation
Standard Error 1.3
8.7 % change in blood vessel dilation
Standard Error 1.3

SECONDARY outcome

Timeframe: Day 14

Fasting vitamin C concentration, biomarker of oxidative stress

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Vitamin C
47.5 umol/L
Standard Error 2.9
52.5 umol/L
Standard Error 4.8

SECONDARY outcome

Timeframe: Day 14

Carotid intima-media thickness. Mean thickness of left and right carotid artery intima media.

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
cIMT
0.603 mm
Standard Deviation 0.109
0.609 mm
Standard Deviation 0.114

SECONDARY outcome

Timeframe: Day 14

Body mass index calculated as kg weight per meters squared

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Day 14 BMI
35.1 kg/m^2
Standard Error 1.1
35.2 kg/m^2
Standard Error 1.1

SECONDARY outcome

Timeframe: Day 0

Waist circumference in centimeters

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Day 0 Waist Circumference
108.5 cm
Standard Error 2.2
119.1 cm
Standard Error 2.2

SECONDARY outcome

Timeframe: Day 14

Waist circumference in centimeters

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Day 14 Waist Circumference
107.8 mmHg
Standard Error 2.4
107.5 mmHg
Standard Error 2.4

SECONDARY outcome

Timeframe: Day 0

Diastolic blood pressure on Day 0

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Day 0 Diastolic Blood Pressure
81.5 mmHg
Standard Error 1.3
81.9 mmHg
Standard Error 1.5

SECONDARY outcome

Timeframe: Day 14

Diastolic blood pressure on Day 14

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Day 14 Diastolic Blood Pressure
75.9 mmHg
Standard Error 1.7
77.7 mmHg
Standard Error 1.4

SECONDARY outcome

Timeframe: Day 0

Systolic blood pressure on Day 0

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Day 0 Systolic Blood Pressure
123.1 mmHg
Standard Error 1.9
119.1 mmHg
Standard Error 2.2

SECONDARY outcome

Timeframe: Day 14

Systolic blood pressure on Day 14

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Day 14 Systolic Blood Pressure
113.6 mmHg
Standard Error 1.9
114.6 mmHg
Standard Error 1.8

SECONDARY outcome

Timeframe: Day 0

Body mass index calculated as kg weight per meters squared

Outcome measures

Outcome measures
Measure
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
Day 0 BMI
35.6 kg/m^2
Standard Error 1.2
35.7 kg/m^2
Standard Error 1.2

Adverse Events

Bagel Diet

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Potato Diet

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Richard Bruno, Principal Investigator

The Ohio State University

Phone: 6142925522

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place